Fresenius Medical Care AG & Co. KGaA ADR logo

Fresenius Medical Care AG & Co. KGaA ADR (FMS)

Market Open
16 Dec, 14:45
NYSE NYSE
$
23. 79
+0.15
+0.63%
$
13.96B Market Cap
20.41 P/E Ratio
4.87% Div Yield
22,541 Volume
0 Eps
$ 23.64
Previous Close
Day Range
23.72 23.85
Year Range
22.05 30.46
Want to track FMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 70 days
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y

Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y

FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income.

Zacks | 9 months ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 9 months ago
Fresenius Medical Care slightly beats market estimates in fourth quarter

Fresenius Medical Care slightly beats market estimates in fourth quarter

Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments.

Reuters | 9 months ago
Fresenius Medical Care: A 'Buy' Going Into 2025

Fresenius Medical Care: A 'Buy' Going Into 2025

Fresenius Medical Care is a leader in global kidney care, showing significant growth and an 18.5% increase since my last article. The company is attractively valued, trading at less than 18.5x P/E, with a fair value estimate of at least $34/share. Risks include political factors in the US healthcare system and technological advancements, but the company's diversification and home-care model are strong positives.

Seekingalpha | 10 months ago
Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Fresenius (FMS) Upgraded to Strong Buy: Here's What You Should Know

Fresenius (FMS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 11 months ago
Best Income Stocks to Buy for January 7th

Best Income Stocks to Buy for January 7th

PRMB, FMS and RBA made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 7, 2024.

Zacks | 11 months ago
Best Momentum Stocks to Buy for December 27th

Best Momentum Stocks to Buy for December 27th

PAYO, TTDKY and FMS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 27, 2024.

Zacks | 11 months ago
Leadership in Dialysis Services and Products Drives FMS Stock

Leadership in Dialysis Services and Products Drives FMS Stock

Fresenius Medical Care leads global dialysis services, driving growth through innovation, restructuring and a strong global footprint in 120+ countries.

Zacks | 0 year ago
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Here's Why Fresenius (FMS) is a Strong Value Stock

Here's Why Fresenius (FMS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?

Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Loading...
Load More